Association between FDA black box warnings and Medicare formulary coverage changes.
Yale School of Medicine, 333 Cedar St, SHM I-456, Box 208088, New Haven, CT 06520-8088. E-mail: [email protected]
- Published Article
The American journal of managed care
- Publication Date
Sep 01, 2017
Medicare formularies became more restrictive for half of the drugs that recently received new FDA black box warnings for death and/or cardiovascular risk and for which safer drug alternatives are available. However, a substantial proportion of formularies remained unrestrictive, suggesting inconsistent responses to new safety information to curtail the use of these medications.
Report this publication
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
This record was last updated on 06/09/2018 and may not reflect the most current and accurate biomedical/scientific data available from NLM.
The corresponding record at NLM can be accessed at https://www.ncbi.nlm.nih.gov/pubmed/29087169